Real-World Outcomes of Patients Starting Intravenous and Transitioning to Subcutaneous Vedolizumab in Inflammatory Bowel Disease
DIGESTIVE DISEASES AND SCIENCES(2024)
Key words
Inflammatory bowel disease,Vedolizumab,Real-world data,Observational study
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined